Cargando…
Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection
The advent of the replicon system together with advances in cell culture have contributed significantly to our understanding of the function of virally-encoded structural and nonstructural proteins in the replication cycle of the hepatitis C virus. In addition, in vitro systems have been used to ide...
Autores principales: | Hopkins, Sam, Gallay, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509662/ https://www.ncbi.nlm.nih.gov/pubmed/23202494 http://dx.doi.org/10.3390/v4112558 |
Ejemplares similares
-
Curing a viral infection by targeting the host: The example of cyclophilin inhibitors
por: Lin, Kai, et al.
Publicado: (2013) -
Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection
por: Hansson, Magnus Joakim, et al.
Publicado: (2015) -
Both Cyclophilin Inhibitors and Direct-Acting Antivirals Prevent PKR Activation in HCV-Infected Cells
por: Bobardt, Michael, et al.
Publicado: (2014) -
The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication
por: Foster, R.T., et al.
Publicado: (2017) -
Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175
por: Gallay, Philippe A., et al.
Publicado: (2016)